MIG, human recombinant protein
Monokine Induced by Interferon-γ, CXCL9
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | Q07325 |
---|---|
Calculated MW | 11.7 kDa |
Gene ID | 4283 |
---|---|
Gene Symbol | CXCL9 |
Other Names | Monokine Induced by Interferon-γ, CXCL9, Gamma-interferon-induced monokine, Small-inducible cytokine B9 |
Gene Source | Human |
Source | E. coli |
Assay&Purity | SDS-PAGE; ≥95% |
Assay2&Purity2 | HPLC; ≥95% |
Recombinant | Yes |
Results | 10 -100 ng/ml |
Target/Specificity | MIG |
Application Notes | Reconstitute in H₂O to a concentration of 1 mg/ml. The solution can be diluted into other buffered solutions or store at –20°C for future use. |
Format | Lyophilized protein |
Storage | -20°C; Sterile filtered and then lyophilized with no additives |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
Human MIG (monokine induced by interferon γ) is produced by microphages and other cells. It is a member of the α chemokine family (C-X-C) of cytokines. MIG acts as a chemoattractant toward monocytes, lymphocytes, and certain T cells. Human MIG is an 11.7 kDa protein that consists of 103 amino acid residues.
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.